Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

TEVA PHARMS USA

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 31
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

BDSI

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 35
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE

Comment Full text

PURDUE PHARMA LP

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 30
  • 0 comments

FDA approve HYDROCODONE BITARTRATE

Comment Full text

HOSPIRA INC

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 38
  • 0 comments

FDA approve MORPHINE SULFATE

Comment Full text

MAINPOINTE

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 36
  • 0 comments

FDA approve CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE

Comment Full text

SOVEREIGN PHARMS

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 34
  • 0 comments

FDA approve GUAIFENESIN; HYDROCODONE BITARTRATE

Comment Full text

OREXO US INC

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 38
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 34
  • 0 comments

FDA approve MORPHINE SULFATE

Comment Full text

LARKEN LABS INC

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 40
  • 0 comments

FDA approve ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE

Comment Full text

AVANTHI INC

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 35
  • 0 comments

FDA approve OXYMORPHONE HYDROCHLORIDE

Comment Full text
  • Previous
  • 608
  • 609
  • 610
  • 611
  • 612
  • Next

Search

News categories

  • Technical Exchange News(11949)
  • Event(4850)
  • SEC News(244791)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(147685)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin